USA - NASDAQ:BCOV - US10921T1016 - Common Stock
ChartMill assigns a Buy % Consensus number of 46% to BCOV. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-25 | Rosenblatt | Downgrade | Buy -> Neutral |
| 2024-11-05 | Lake Street | Upgrade | Hold -> Buy |
| 2024-02-23 | Lake Street | Downgrade | Buy -> Hold |
| 2024-02-23 | Rosenblatt | Maintains | Buy -> Buy |
| 2023-08-03 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-08-01 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-07-31 | Lake Street | Upgrade | Hold -> Buy |
| 2023-06-12 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-05-31 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-05-04 | Lake Street | Maintains | Hold |
| 2023-04-26 | Rosenblatt | Reiterate | Buy |
| 2023-02-24 | Rosenblatt | Reiterate | Buy |
| 2023-02-13 | Rosenblatt | Upgrade | Neutral -> Buy |
| 2022-09-09 | Rosenblatt | Initiate | Neutral |
| 2022-02-17 | Lake Street | Downgrade | Buy -> Hold |
| 2021-10-28 | Northland Capital Markets | Downgrade | Outperform -> Market Perform |
7 analysts have analysed BCOV and the average price target is 4.54 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 4.45.
The consensus rating for BRIGHTCOVE (BCOV) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.